Dr Mayoni Gooneratne examines systemic peptide use in longevity and wellness practice Peptide-based drugs have moved rapidly from niche therapeutics to a major growth area across endocrine, metabolic, oncologic and rare disease medicine.¹⁻⁴ At the same time, a parallel market …
To access this post, you must purchase Aesthetics Journal Subscriptions – AJ Print & Digital Subscriber or Aesthetics Journal Subscriptions – AJ Digital Subscriber.
log in
log in
